辛开苦降经方治疗溃疡性结肠炎药理机制研究进展
张罡 顾思臻 刘晓雯 窦丹波
上海中医药大学附属曙光医院传统中医科,上海 201203
Research progress on pharmacological mechanism of Xinkai Kujiang classic prescriptions intervention in the treatment of ulcerative colitis
ZHANG Gang GU Sizhen LIU Xiaowen DOU Danbo
Department of Traditional Medicine, ShuGuang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, ShangHai 201203, China
摘要 寒热错杂病机贯穿溃疡性结肠炎始终,治宜辛开苦降。半夏泻心汤、甘草泻心汤、乌梅丸等相关经方在使用时可以发挥较好的疗效,尤其在缓解临床症状,提高患者生存质量等方面。但药理机制研究尚不明确,可能是通过抑制NLRP3炎症小体、抑制IL-6/STAT3信号通路、抑制TLR4/NF-κB信号通路等调节炎症平衡;或调节肠黏膜生物屏障;或抑制过度的细胞凋亡实现的。本文通过梳理近几年辛开苦降法治疗溃疡性结肠炎的机制研究,为中医药治疗溃疡性结肠炎的良好作用提供理论依据,从而为进一步的药物研究指明方向。
关键词 :
溃疡性结肠炎 ,
经方 ,
半夏泻心汤 ,
甘草泻心汤 ,
乌梅丸
Abstract :The pathogenesis of cold and heat interspersed is throughout ulcerative colitis, it’s should be treated with Xinkai Kujiang. Banxia Xiexin Decoction, Gancao Xiexin Decoction, Wumei Pills, and other related prescriptions can play a good curative effect when used, especially in relieving clinical symptoms, improve patients’ quality of life and so on. However, the pharmacological mechanism is still unclear. It may regulate the inflammatory balance by inhibiting the NLRP3 inflammatorome, IL-6/STAT3 signaling pathway, and TLR4/NF-κB signaling pathway; or regulate intestinal mucosal biological barrier; or inhibition of excessive apoptosis. In this paper, the mechanism of Xinkai Kujiang treatment for ulcerative colitis has been reviewed in recent years, so as to provide theoretical basis for the good effect of traditional Chinese medicine on ulcerative colitis and point out the direction for further drug research.
Key words :
Ulcerative colitis
Classic prescriptions
Banxia Xiexin Decoction
Gancao Xiexin Decoction
Wumei Pills
基金资助: 国家自然科学基金资助项目(82174288)。
通讯作者:
窦丹波(1971.10-),男,博士,教授,主任医师;研究方向:中医脾胃病、中医药国际标准化。
作者简介 : 张罡(1997.1-),男,上海中医药大学2020级中医内科学专业在读硕士研究生;研究方向:中医药治疗脾胃病。
[1] Rogler G,Singh A,Kavanaugh A,et al. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts,Treatment,and Implications for Disease Management [J]. Gastroenterology,2021,161(4):1118-1132.
[2] 李军祥,陈誩.溃疡性结肠炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):105-111.
[3] Xiong X,Cheng Z,Wu F,et al. Berberine in the treatment of ulcerative colitis:A possible pathway through Tuft cells [J]. Biomed Pharmacother,2021,134:111129.
[4] 高阳,顾思臻,陈侃俊,等.窦丹波应用青玉散治疗溃疡性结肠炎的思考和临证体会[J].中华中医药杂志,2021, 36(9):5311-5315.
[5] Wei Y,Fan Y,Ga Y,et al. Shaoyao decoction attenuates DSS- induced ulcerative colitis,macrophage and NLRP3 inflammasome activation through the MKP1/NF-κB pathway [J]. Phytomedicine,2021,92:153743.
[6] 李鹏帆,窦丹波.溃疡性结肠炎中医证候研究进展[J].上海中医药大学学报,2020,34(2):107-112.
[7] 王志愿,张宁怡,吴珊珊,等.基于因子分析与聚类分析对溃疡性结肠炎中医证候的研究[J].中国医药导报,2019, 16(30):163-167.
[8] 赵鲁卿,吴茜,张声生.张声生教授以“寒热”为纲辨治溃疡性结肠炎的思路和治疗策略[J].中国中西医结合消化杂志,2021,29(2):141-143.
[9] 周鸿威,于会勇,王成祥.基于“辛开苦降”理论治疗特发性肺纤维化合并胃食管反流的探讨[J].中国医药导报,2021,18(17):130-133.
[10] 闫成秋,周建华,司永梅,等.周建华教授运用辛开苦降法治疗溃疡性结肠炎经验[J].吉林中医药,2022,42(7):782-784.
[11] 顾思臻,薛艳,高阳,等.青黛对溃疡性结肠炎肠上皮细胞炎症模型的抗炎机制研究[J].中药药理与临床,2021,37(6):67-71.
[12] 赵卓,刘林,宋囡,等.半夏泻心汤对溃疡性结肠炎大鼠NLRP3/Caspase-1细胞焦亡信号通路的影响[J].中国实验方剂学杂志,2022,28(16):29-34.
[13] Salas A,Hernandez-Rocha C,Duijvestein M,et al. JAK- STAT pathway targeting for the treatment of inflammatory bowel disease [J]. Nat Rev Gastroenterol Hepatol,2020,17(6):323-337.
[14] Zhong C,Cheng X,Jia B,et al. Gancao Xiexin decoction combined with mesalazine in the treatment of ulcerative colitis [J]. Medicine,2020,99(47):e23038.
[15] 郭琴,张立石,王颖,等.乌梅丸及其拆方对TNBS致溃疡性结肠炎大鼠的作用研究[J].中国中医基础医学杂志,2021,27(7):1099-1103.
[16] 李杰,陈盈盈,王昆,等.基于TLR4/MyD88信号通路探讨刺糖多糖对溃疡性结肠炎小鼠的作用及机制[J].中药新药与临床药理,2022,33(9):1143-1148.
[17] Yu Y,Zhang G,Han T,et al. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module [J]. BMC Complement Med Ther,2020,20(1):199.
[18] Lu D,Liu F,Wu H,et al. Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation [J]. World J Gastroenterol,2022,28(32):4574-4599.
[19] Wang W,Xu C,Li X,et al. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS- induced ulcerative colitis rats with the assistance of network pharmacology analysis [J]. J Ethnopharmacol,2021, 277:114197.
[20] Chu H,Khosravi A,Kusumawardhani IP,et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease [J]. Science,2016,352(6289):1116-1120.
[21] Chen F,Chen J,Chen Q,et al. Lactobacillus delbrueckii Protected Intestinal Integrity,Alleviated Intestinal Oxidative Damage,and Activated Toll-Like Receptor-Bruton’s Tyrosine Kinase-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Weaned Piglets Challenged with Lipopoly- saccharide [J]. Antioxidants(Basel),2021,10(3):468.
[22] 陈健,张梁坤,谷文超,等.半夏泻心汤对右旋葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠肠道菌群的影响[J].中国中药杂志,2021,46(11):2871-2880.
[23] 陈浩,徐佳佳,王国庆,等.基于肠道屏障功能研究甘草泻心汤治疗溃疡性结肠炎的作用机制[J].时珍国医国药,2018,29(10):2378-2380.
[24] Luo Y,Wu J,Zhu F,et al. Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites [J]. Drug Des Devel Ther,2022, 16:1383-1405.
[25] Lehle AS,Farin HF,Marquardt B,et al. Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency [J]. Gastroenterology,2019,156(1):275-278.
[26] 陈浩彬,林才志.乌梅丸治疗大肠相关性疾病的研究进展[J].中国实验方剂学杂志,2023,29(1):250-257.
[27] 闫曙光,惠毅,李倩,等.黄连-干姜提取物对溃疡性结肠炎小鼠结肠上皮TLR4/NF-κB信号通路的影响[J].中国实验方剂学杂志,2020,26(4):70-75.
[28] Zhang H,Dong R,Zhang P,et al. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl2/Bax and GSK3β/β-catenin signaling pathways [J]. Oncol Rep,2019,41(5):3069-3079.
[29] 周步高,刘馥春,张晓云,等.乌梅丸治疗溃疡性结肠炎作用机制的研究进展[J].时珍国医国药,2018,29(11):2731-2733.
[30] 顾思臻,窦丹波.内质网应激与溃疡性结肠炎病变机制的研究现状[J].中国中西医结合消化杂志,2017,25(2):156-159.
[31] 沈雁,王章流,钟继红,等.基于PERK-eIF2α-NF-κB信号通路研究甘草酸苷对小鼠肠上皮细胞内质网应激的保护作用[J].中国现代应用药学,2022,39(11):1389-1394.
[32] 沈雁,钟继红,倪思忆,等.甘草泻心汤调控PERK- elF2α-CHOP信号通路保护应激态肠上皮细胞屏障的机制[J].中国药理学通报,2021,37(5):717-723.
[1]
孙洁1 史肖华1 李彩云2 季士亮2. 白头翁皂苷B4基于调节巨噬细胞极化对小鼠溃疡性结肠炎的影响 [J]. 中国医药导报, 2023, 20(7): 27-31.
[2]
房子铭1 孙志文2 谢晶日2. 基于肠道菌群探讨中药治疗溃疡性结肠炎的研究进展 [J]. 中国医药导报, 2023, 20(6): 42-45,58.
[3]
黄灿 毛堂友 孙中美 李军祥 张文基 王志斌. 溃疡性结肠炎中的色氨酸代谢及作用机制 [J]. 中国医药导报, 2023, 20(6): 55-58.
[4]
韩玲1 陈琴2 谢昌营3 黄雪云4 吴娜4. 基于生物信息学分析miR-143调控TLR2信号通路对溃疡性结肠炎的影响 [J]. 中国医药导报, 2023, 20(13): 13-17.
[5]
段婷1 刘俊1 刘洁2 高亚娜1▲. 溃疡性结肠炎患者健康心理控制源与健康促进行为调查 [J]. 中国医药导报, 2023, 20(12): 74-77.
[6]
张亮亮1 杨帅2 于金德3 李佳珂2 李乾构2 汪红兵2▲. 李乾构教授基于“病有脾,治肝肺”论治溃疡性结肠炎的经验 [J]. 中国医药导报, 2023, 20(10): 113-116.
[7]
杨雅钦1 张朵1 李国秋2 刘超男3. 基于VOSviewer和CiteSpace的半夏泻心汤知识图谱可视化分析 [J]. 中国医药导报, 2022, 19(9): 16-20,36.
[8]
陈梦雪 王宏刚 谢睿▲. 溃疡性结肠炎中巨噬细胞差异基因及功能分析 [J]. 中国医药导报, 2022, 19(7): 27-30.
[9]
刘深梵1 宫宇澄2 寇梦佳2 王志斌2. 多种方案治疗寒热错杂型溃疡性结肠炎的网状meta分析 [J]. 中国医药导报, 2022, 19(35): 110-114.
[10]
郭玉娜1 陈丽名2 刘坤1. 经方在心力衰竭中的临床应用 [J]. 中国医药导报, 2022, 19(30): 116-119.
[11]
王晓瑜 缪志伟 张耀辉 张春雨 徐艳. 清肠汤联合美沙拉嗪治疗热盛血瘀型活动期溃疡性结肠炎患者的临床效果及其作用机制 [J]. 中国医药导报, 2022, 19(19): 115-119.
[12]
陈美艳1 曾霖1 李茂生2 卢赵琦1 李惠林2. 李惠林教授活用经方治疗脱发经验撷要 [J]. 中国医药导报, 2022, 19(12): 134-137,146.
[13]
吴会晓 蔡毅东. 基于CiteSpace中医药治疗溃疡性结肠炎的可视化分析 [J]. 中国医药导报, 2022, 19(11): 16-20.
[14]
丁亮1 肖燕2▲. 半夏泻心汤配合针刺治疗寒热错杂型慢性萎缩性胃炎的效果 [J]. 中国医药导报, 2021, 18(35): 167-170.
[15]
刘敏 王小燕 贾瑞琳 任存霞. 当归芍药散优化方抗慢性盆腔炎的实验研究 [J]. 中国医药导报, 2021, 18(3): 17-20.